Literature DB >> 26009171

Regulation and roles of elongation factor 2 kinase.

Christopher G Proud1.   

Abstract

Eukaryotic elongation factor 2 kinase (eEF2K) belongs to the small family of atypical protein kinases termed α-kinases, and is the only calcium/calmodulin (Ca/CaM)-dependent member of that group. It phosphorylates and inactivates eEF2, to slow down the rate of elongation, the stage in mRNA translation that consumes almost all the energy and amino acids consumed by protein synthesis. In addition to activation by Ca/CaM, eEF2K is also regulated by an array of other regulatory inputs, which include inhibition by the nutrient- and growth-factor activated signalling pathways. Recent evidence shows that eEF2K plays an important role in learning and memory, processes that require the synthesis of new proteins and involve Ca-mediated signalling. eEF2K is activated under conditions of nutrient and energy depletion. In cancer cells, or certain tumours, eEF2K exerts cytoprotective effects, which probably reflect its ability to inhibit protein synthesis, and nutrient consumption, under starvation conditions. eEF2K is being evaluated as a potential therapeutic target in cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26009171     DOI: 10.1042/BST20140323

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  36 in total

Review 1.  Molecular regulation of human skeletal muscle protein synthesis in response to exercise and nutrients: a compass for overcoming age-related anabolic resistance.

Authors:  Nathan Hodson; Daniel W D West; Andrew Philp; Nicholas A Burd; Daniel R Moore
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-28       Impact factor: 4.249

Review 2.  Cross-talk between protein synthesis, energy metabolism and autophagy in cancer.

Authors:  Lisa M Lindqvist; Kristofferson Tandoc; Ivan Topisirovic; Luc Furic
Journal:  Curr Opin Genet Dev       Date:  2017-11-25       Impact factor: 5.578

3.  Repression of eEF2K transcription by NF-κB tunes translation elongation to inflammation and dsDNA-sensing.

Authors:  Christopher Bianco; Letitia Thompson; Ian Mohr
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-21       Impact factor: 11.205

Review 4.  Protein Translation and Psychiatric Disorders.

Authors:  Sophie Laguesse; Dorit Ron
Journal:  Neuroscientist       Date:  2019-07-04       Impact factor: 7.519

5.  MYCN amplified neuroblastoma requires the mRNA translation regulator eEF2 kinase to adapt to nutrient deprivation.

Authors:  Alberto Delaidelli; Gian Luca Negri; Asad Jan; Brandon Jansonius; Amal El-Naggar; Jonathan K M Lim; Debjit Khan; Htoo Zarni Oo; Christopher J Carnie; Marc Remke; John M Maris; Gabriel Leprivier; Poul H Sorensen
Journal:  Cell Death Differ       Date:  2017-06-02       Impact factor: 15.828

6.  eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis.

Authors:  Y Cheng; X Ren; Y Yuan; Y Shan; L Li; X Chen; L Zhang; Y Takahashi; J W Yang; B Han; J Liao; Y Li; H Harvey; A Ryazanov; G P Robertson; G Wan; D Liu; A F Chen; Y Tao; J-M Yang
Journal:  Oncogene       Date:  2016-05-16       Impact factor: 9.867

Review 7.  Dysregulation of mRNA translation and energy metabolism in cancer.

Authors:  Matthew Leibovitch; Ivan Topisirovic
Journal:  Adv Biol Regul       Date:  2017-11-02

Review 8.  Translational Control in the Brain in Health and Disease.

Authors:  Wayne S Sossin; Mauro Costa-Mattioli
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-08-01       Impact factor: 10.005

9.  Repression of eEF2 kinase improves deficits in novel object recognition memory in aged mice.

Authors:  Saahj P Gosrani; Hannah M Jester; Xueyan Zhou; Alexey G Ryazanov; Tao Ma
Journal:  Neurobiol Aging       Date:  2020-07-25       Impact factor: 4.673

10.  Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer's model mice.

Authors:  Helena R Zimmermann; Wenzhong Yang; Nicole P Kasica; Xueyan Zhou; Xin Wang; Brenna C Beckelman; Jingyun Lee; Cristina M Furdui; C Dirk Keene; Tao Ma
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.